Abstract:NANOG is an important stem cell transcription factor involved in human development and cancerogenesis. Its expression is complex and regulated on different levels. Moreover, NANOG protein might regulate hundreds of target genes at the same time. NANOG is crucial for preimplantation development phase and progressively decreases during embryonic stem cells differentiation, thus regulating embryonic and fetal development. Postnatally, NANOG is undetectable or expressed in very low amounts in the majority of human tissues. NANOG re-expression can be detected during cancerogenesis, already in precancerous lesions, with increasing levels of NANOG in high grade dysplasia. NANOG is believed to enable cancer cells to obtain stem-cell like properties, which are believed to be the source of expanding growth, tumor maintenance, metastasis formation, and tumor relapse. High NANOG expression in cancer is frequently associated with advanced stage, poor differentiation, worse overall survival, and resistance to treatment, and is therefore a promising prognostic and predictive marker. We summarize the current knowledge on the role of NANOG in cancerogenesis and development, including our own experience. We provide a critical overview of NANOG as a prognostic and diagnostic factor, including problems regarding its regulation and detection. Impact statement NANOG has emerged as a key stem cell transcription factor in normal development and cancerogenesis. It is generally regarded as a good prognostic and predictive factor in various human cancers. It is less known that it is expressed already at precancerous stages in various organs, suggesting that finally an ideal candidate diagnostic marker has been discovered, enabling to distinguish between true dysplasia and reactive atypia. NANOG regulation is complex, and new insights into our understanding of its regulation might provide important information for future development in a broad field of two entirely different processes, i.e. normal development and cancerogenesis, showing how a physiologic mechanism can be used and abused, transforming itself into a key mechanism of disease development and progression.

The Roles of NANOG in Tumorigenesis

Regulation of NANOG in cancer cells

Pluripotency Factor Nanog is Tumorigenic by Deregulating DNA Damage Response in Somatic Cells

Nanog in human tumors and stem cells

The Pluripotency Factor Nanog Promotes Breast Cancer Tumorigenesis and Metastasis

Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade.

NANOG expression in human development and cancerogenesis

Insights into the Nanog gene: A propeller for stemness in primitive stem cells

Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions

NANOGP8 is a retrogene expressed in cancers.

Stem-cell-abundant Proteins Nanog, Nucleostemin and Musashi1 Are Highly Expressed in Malignant Cervical Epithelial Cells

Abstract 5413: Role of NANOG in Modulating Cancer Cell Metabolism.

Stem Cell Transcription Factor NANOG Controls Cell Migration and Invasion Via Dysregulation of E-cadherin and FoxJ1 and Contributes to Adverse Clinical Outcome in Ovarian Cancers.

The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development

Concise Review: Pursuing Self-Renewal and Pluripotency with the Stem Cell Factor Nanog

Pluripotential competence of cells associated with Nanog activity

Expression of NANOG in Human Gliomas and Its Relationship with Undifferentiated Glioma Cells

The oncogenic potential of NANOG: An important cancer induction mediator

Nanog safeguards pluripotency and mediates germline development

Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human

Overexpression of Nanog Protein is Associated with Poor Prognosis in Gastric Adenocarcinoma